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In the present work, we have analyzed the effect of the 
essential fatty acid, alpha linolenic acid (ALA) on ni-
tric oxide release as well as induction of lipid peroxi-
dation in breast (MCF-7 and MDA-MB-231) and cer-
vical (SiHa and HeLa) cancer cell lines. ALA-treated 
cells showed a dose-dependent decrease in cell viabil-
ity in both breast and cervical cancer cell lines without 
affecting  the  viability  of  non-cancerous  transformed 
HEK 293 cells. Both types of cancer cells treated with 
ALA demonstrated a significant reduction in nitric 
oxide (NO) release with  a simultaneous increase in 
lipid peroxidation (LPO). This was followed by a de-
crease in the mitochondrial membrane potential as well 
as activation of caspase 3 leading to apoptosis. Thus, 
ALA  regulated  the  growth  of  cancer  cell  lines 
through induction of lipid peroxidation and modu-
lation of nitric oxide release resulting in apoptosis. 
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Alpha-linolenic acid regulates the growth of breast and cervical cancer 
cell lines through regulation of NO release and induction of lipid 
peroxidation 
Introduction 
 
Alpha-linolenic  acid  (ALA  18:3),  an  omega-3  (n-3) 
fatty acid, is an essential fatty acid (EFA) that cannot 
be synthesized by the human body and thus must be 
obtained from dietary sources. ALA is found mostly in 
certain  plant  foods  that  include  walnuts,  rapeseed 
(canola),  several  legumes,  flaxseed  and  green  leafy 
vegetables  (Barceló-Coblijn  &  Murphy  2009, 
Bougnoux et al. 2010). ALA is the parent n3 fatty acid 
and gets converted into longer chain fatty acids such as 
Eicosapentaenoic  (EPA  20:5,  ω3)  and  Docosahex-
aenoic acid (DHA 22:6, ω3) that are well known for 
their  various  functions  including    cardio-protection, 
anti-inflammatory, anticancer as well as brain develop-
ment (Allayee  et al. 2009, Burdge et al. 2005, Stark et 
al. 2008, Zhao G et al. 2004). There is a vast amount 
of research on EPA and DHA derived from fish oil; 
however,  very  few  studies  have  been  conducted  on 
ALA present in plants.  
A number of  studies have reported that essen-
tial fatty acids selectively kill tumor cells through the 
generation of free radicals as well as lipid peroxidation 
(Das et al. 1999, 2000). Free radicals in the form of 
ROS (reactive oxygen species) and RNS (reactive ni-
trogen  species)  are  known  to  cause  oxidation    of 
biomembranes as well as modulation of  inter- and in-
tracellular signaling networks resulting in changes of 
cell  proliferation,  differentiation  and  apoptosis  (Das 
2002,  Sun  et  al.  2012).  Nitric  oxide,  a  measure  of 
RNS,  is  an  endogenously  produced  free  radical  that 
has been known to either promote or inhibit lipid per-
oxidation (Hogg & Kalyanaraman 1999). The enzyme 
responsible for the conversion of L-arginine to NO is 
the nitric oxide synthase (NOS) that exists in three ma-
jor  isoforms;  inducible  (NOS  II/iNOS),  endothelial 
(NOS III/eNOS) and neuronal NOS (NOS I/nNOS). In 
cancer cells, it has been shown that increased NO gen-
erated by iNOS contributes to tumor angiogenesis by 
the up-regulation of vascular endothelial growth factor 
(VEGF),  which  may  increase  tumor  metastasis 
(Nakamura et al. 2006). Increased release of NO in the 
cervix has also been shown to be associated with HPV 
infection  in  cases  of  cervical  cancer  (Rahkola  et  al. 
2009, Wei et al. 2009). 
Nitric oxide has been reported to be a potent 
inhibitor of the lipid peroxidation chain reaction and 
has been shown to inhibit peroxidase enzymes that are 
potential initiators of the former process. Conversely, 
in the presence of superoxide, nitric oxide forms per-
oxynitrite that can initiate lipid peroxidation and oxi-
dize lipid soluble antioxidants (Gago-Dominguez et al. 
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1999,  Xu  et  al.  2002).  The  cell  membranes  contain 
high concentrations of polyunsaturated fatty acids and 
are thus susceptible to peroxidation, which is a critical 
mechanism leading to growth inhibition and cell death 
(Gago-Dominguez et al. 2007). 
  In the present study, we analyzed the effect of 
ALA, an omega 3 fatty acid, on breast and cervical 
cancer cell lines in terms of cell viability, nitric oxide 
generation as well as status of lipid peroxidation. We 
observed  that  ALA  decreased  the  viability  of  both 
breast and cervical cancer cells in a significant manner, 
albeit, at higher doses and higher exposure times. In-
terestingly ALA regulated the growth of both types of 
cancer cells through an increase in lipid peroxidation 
and  a  reduction  in  nitric  oxide  generation.  This  re-
sulted in loss of the mitochondrial membrane potential 
of the cells leading to apoptosis through activation of 
the caspase 3 pathway. 
 
Materials and Methods 
 
Reagents 
Tissue culture plasticware was purchased from BD Bio
-sciences, CA, USA. Alpha linolenic acid, fatty acid-
free  bovine  serum  albumin  (BSA)  and  3-(4,  5-
dimethylthiazol-2-yl)-2,  5-diphenylthiazoliumbromide 
(MTT) were purchased from Sigma-Aldrich, St. Louis, 
MO,  USA.  Dulbecco's  Modified  Eagles  Medium 
(DMEM), Penicillin and streptomycin were obtained 
from Gibco BRL, USA. Fetal bovine serum was pur-
chased  from  Moregate  Biotech,  Australia.  L-
Glutamine, BHT and TBA were obtained from Hime-
dia  Corporation,  Mumbai,  India.  Sulfanilamide  was 
purchased from Qualigens, N-[1-napthyl] ethylenedia-
mine (NEDD) was purchased from SRL and TCA was 
purchased from Merck. 
 
Cell culture 
The human breast adenocarcinoma (MCF-7 and MDA 
MB231)  and  cervical  cancer    (SiHa  and  HeLa)  cell 
lines as well as the human embryonic kidney cell line 
(HEK293) used in this study were obtained from the 
National Centre for Cell Science (NCCS), Pune, India. 
The cells were grown in DMEM containing 2 mM L-
glutamine supplemented with 10% fetal bovine serum 
and  100  U/ml  of penicillin-streptomycin.  They  were 
incubated in a humidified 5% CO2 incubator at 37°C. 
 
Conjugation of Alpha linolenic acid with BSA  
ALA was reconstituted in 200 µL of ethanol. For con-
jugation, ALA (10mM) was added to fatty acid-free 
bovine serum albumin (BSA) (3mM) to obtain a ~3:1 
ratio of ALA: BSA (Mahadik et al. 1996). The conju-
gated omega fatty acids were incubated at 37˚C for 30 
min in a CO2 incubator and stored at -20˚C. Before use 
they were diluted to the required concentration with 
10% DMEM. 
 
Cell Viability Assay 
Cell viability was measured using the MTT assay in 
breast (MCF-7 and MDA-MB-231) and cervical can-
cer cell lines in the presence of different concentrations 
of ALA and compared with the non-cancerous trans-
formed cell line, HEK 293. The cells were seeded at a 
density  of  1  ×  10
5  cells/ml  in  96-well  plates  (TPP, 
Europe/Switzerland)  and  grown  for  24  h.  ALA  was 
added at different concentrations: 0-320μM for 24, 48 
and 72 h. The MTT solution (5 mg/ml) was added to 
each well and the cells were cultured for another 4 h at 
37°C in a 5% CO2 incubator. The formazan crystals 
formed  were  dissolved in  90  μl  of  SDS-DMF  (20% 
SDS in 50% DMF) (Singh et al. 2009). After 15 min, 
the amount of colored formazan derivative was deter-
mined by measuring optical density (OD) at 570 nm 
using the ELISA micro plate reader (Bio-Rad, Hercu-
les, CA). 
 
Nitric Oxide assay 
The concentration of NO was indirectly determined in 
culture supernatants as nitrite, a major stable product 
of NO. The cells (breast and cervical cancer cell lines) 
were seeded at a density of 1x10
5 cells/ml in 96-well 
plates  (TPP,  Europe/Switzerland)  for  24  h  and  then 
incubated with different concentrations of ALA (0-80 
μM) for different time intervals (24, 48 and 72 h). The 
NO  levels  were  estimated  by  the  Griess  reaction 
(Udenigwe et al. 2009). Briefly, 100 µL of culture su-
pernatant was mixed with an equal volume of Griess 
reagent [1% sulfanilamide and 0.1% N-(1-naphthyl)-
ethylenediamine in 5% phosphoric acid) and incubated 
at room temperature for 10 min. The absorbance at 540 
nm was measured with the ELISA micro plate reader 
(Bio-Rad,  Hercules,  CA).  Nitric  oxide  concentration 
was  determined  using  sodium  nitrite  (NaNO2)  as  a 
standard.  
 
RT-PCR  
The total cellular RNA from control as well as cells 
treated  with  different  concentrations  of  ALA  (0-80 
μM)  was  extracted  by  a  one-step  acid  guanidine 
isothiocyanate-phenol  method  using  the  TRI  reagent 
(Invitrogen). RNA was precipitated with isopropanol 
and the concentration was estimated using Nanodrop 
(Eppendorff BioPhotometer plus). 10 mg of total RNA 
were  used  for  each  RT-PCR  reaction.  50  units  of 
Moloney murine leukemia virus reverse transcriptase 
(MMuLV) (Bangalore Genei, Bangalore, India) were 
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strand buffer, 1 mM DTT, 2.5 mM dNTPs, 50 ng/μl 
random primers and 15 U/μl RNAse i) and incubated 
for 1 h at 40°C followed by incubation at 95°C for 5 
min. The purified cDNA template was amplified using 
different  sets  of  primers.  The  primers  used  were  β-
actin-F:  5'-taccactggcatcgtgatg-gact-3';  β-actin-R:  5’-
tttctgcatcctgtcggaaat-3';  iNOS-F:  5'-  caga-
taagtgacataagtga-3'; iNOS-R: 5'- ctatctttgttgttgtccttg-3'. 
PCR was performed in 25 μl volume in which 1X PCR 
buffer, 2.5 mM dNTPs, 1.5 mM MgCl2, 1 U of Taq 
polymerase and 100 ng of the specific primers were 
added. A brief initial denaturation at 95°C for 5 min 
was followed by 35 cycles with the following steps: 
95°C for 1 min, annealing at 42°C for 1 min and exten-
sion at 72°C for 1 min. RT-PCR products were then 
separated  on  a  1.2%  agarose  gel  and  visualized  by 
staining with ethidium bromide. The intensities of the 
bands  corresponding  to  the  RT-PCR  products  were 
quantified using phosphor imager (Alpha Imager, Al-
pha Innotech) and normalized with respect to the  β-
actin product. 
 
Lipid peroxidation assay (thiobarbituric acid reac-
tive substance) 
The  generation  of  thiobarbituric  acid  reactive  sub-
stances (TBARS) was measured following a published 
protocol (Ding et al. 2006) with minor modifications. 
Briefly,  the  cells  were  seeded  at  a  density  of 
4x10
5cells/ml  in  6-well  plates  (TPP,  Europe/
Switzerland)  and  were  grown  for  24  h, followed  by 
treatment with different concentrations of ALA (0-80 
μM). After 24 h of treatment, cells were harvested and 
resuspended in 120 µl of 1X PBS. They were homoge-
nized on ice for 10 min using a micro-pestle and then 
centrifuged at 10,000 rpm for 10 min. Following this, 
100 mM butylated hydroxytoluene (1.5 µL), 15% Tri-
chloroacetic  acid  (50  µL),  0.25  mM  butylated  hy-
droxytoluene (50 µL), 0.375% thiobarbituric acid (50 
µL) and 8.5% SDS (20 µL) were added. The samples 
were then vortexed for 5 min. This mixture was incu-
bated  at  80 
oC  for  120  min  and  the  reaction  was 
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Figure 1. ALA alters the viability of breast and cervical cancer cell lines. All cell lines were treated with different doses of ALA 
(0-320µM) for 24, 48 and 72 h. ALA alters the cell viability of MCF-7 (A) and MDAMB231 (B) breast cancer cells as well as 
of SiHa (C) and HeLa (D) cervical cancer cells at 24, 48 and 72 h. All the data are presented as mean ± SEM of three independ-
ent experiments. 
∗p < 0.05 indicates statistically significant differences compared to the control untreated group.  stopped  by  cooling  on  ice  for  10  min.  The  samples 
were centrifuged at 10,000 rpm for 10 min and the su-
pernatant from each tube was transferred to a 96-well 
plate. The optical density was measured at 540 nm us-
ing the ELISA plate reader (Bio-Rad, Hercules CA). 
TBARs  were  calculated  using  1,  1,  3,  3-
tetraethoxypropane (TMP)  as a standard. The result-
ing TBAR values were normalized by the protein con-
centration of each sample that was estimated by the 
Bradford  reagent  (Bio-Rad  Laboratories  Inc,  CA, 
USA). 
 
Mitochondrial membrane potential 
Both breast and cervical cancer cell lines were seeded 
at a density of 1×10
5 cells/ml in a black 96-well plate 
and incubated at 37
oC in a CO2 incubator. The next 
day,  the  cells  were  treated  with  different  concentra-
tions of ALA (0-80 μM) and were incubated in a CO2 
incubator at 37°C for 24 h. The following day, the me-
dium was removed and the cells were washed with 1X 
PBS and incubated with 2.5 μg/ml JC-1 staining solu-
tion (Sigma-Aldrich, St. Louis, MO) for 1 h in the dark 
(Wang et al. 2009). Fluorescence readings were meas-
ured  using  the  Fluostar  Omega  microplate  reader 
(BMG Labtech) at 520 nm for JC-1 monomers and at 
590 nm for JC-1 aggregates. 
 
Immunoblotting 
Cell extracts were prepared from controls as well as 
cells treated with different concentrations of ALA (0-
80 μM). Briefly, the cell pellets were resuspended in 
40 μl lysis buffer containing 50 mM Tris (pH 7.4), 5 
mM EDTA, 0.5% NP40, 50 mM NaF, 1 mM DTT, 0.1 
mM  PMSF,  0.5μg/ml  leupeptin  (Pro-pure  Amersco, 
Solon,  USA),  1  μg/ml  pepstatin  (Amresco,  Solon, 
USA), 150 mM NaCl, 0.5μg/ml aprotinin (Amersco, 
Solon,  USA),  a  protease  inhibitor  cocktail  (Roche, 
Lewes, UK) and incubated on ice for 1 h with intermit-
tent mixing. The extract was centrifuged for 20 min at 
4°C at 12000 rpm. Protein concentration was estimated 
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Figure 2. ALA reduces the nitric oxide release as well as iNOS expression in breast cancer cell lines. Cells were treated with 
different concentrations of ALA (0-80 µM) for 24, 48 and 72 h and the nitric oxide release was measured in MCF7 (A) and 
MDA-MB-231 (B) cells. ALA treatment reduces the iNOS expression at mRNA level in MCF-7 (C) and MDAMB231 (D) 
cells. β-actin was used as the loading control. Densitometric analysis of iNOS expression is shown (E). Values are represented 
as mean ± SEM of five independent experiments, each conducted in triplicates. 
*p < 0.05 indicates statistically significant differ-
ences compared to the untreated control cells. using the Bradford reagent (Biorad Laboratories Inc, 
CA, USA). Equal amounts of protein were loaded on a 
10% SDS-polyacrylamide gel and transferred electro-
phoretically to an Amersham Hybond-P PVDF mem-
brane  (GE  Healthcare,  UK)  in  sodium  phosphate 
buffer  (pH  6.8).  The  membrane  was  blocked  in  5% 
BSA in TBST and incubated at room temperature for 1 
h  with rabbit polyclonal antibody  for  caspase  3 and 
mouse  monoclonal  antibody  for  tubulin  (Santacruz, 
CA, USA) at 1:500 and 1:2000 dilutions, respectively. 
The  membrane  was  washed  in  TBST  and  incubated 
with donkey anti-rabbit IgG HRP conjugate at 1:5000 
(for caspase) and donkey antimouse IgG HRP conju-
gate  at  1:3000  (for  tubulin)  dilutions.  Proteins  were 
visualized using a chemiluminescence kit (Amersham 
ECL  Advance  western  blotting  detection  kit,  GE 
Healthcare, UK) and densitometric analysis of X-ray 
films was performed on the Alpha Imager using the 
Alpha Ease FC software, Alpha Innotech. 
Statistical analysis 
All experiments were performed in triplicates and re-
peated at least three times. The data are presented as 
mean ± SD. Statistical analysis was conducted with the 
Graph Pad 4 prism program using one-way ANOVA. 
The p values used for comparisons were < 0.05. 
 
Results 
 
ALA alters the cell viability of breast and cervical 
cancer cell lines 
Omega 3 fatty acids including, ALA, have been known 
to inhibit the growth of cancer cells (Das et al. 1998, 
Horia & Watkins 2005, Kim et al. 2009, Sagar & Das, 
1995).  In  the  present  report,  we  have  treated  breast 
(MCF7  and  MDA-MB-231)  and  cervical  (SiHa  and 
HeLa) cancer cell lines with different concentrations (0
-320 μM) of ALA for 24, 48 and 72 h. It was observed 
that in breast cancer cell lines, there was an apprecia-
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Figure 3. ALA reduces nitric oxide as well as iNOS levels in cervical cancer cell lines. The cells were treated with different 
concentrations of ALA (0-80 µM) for 24, 48 and 72 h and the nitric oxide release was measured in SiHa (A) and HeLa (B) cells. 
ALA treatment reduces the iNOS expression at mRNA level in SiHa (C) and HeLa (D). β-actin was used as the loading control. 
Densitometric analysis of iNOS expression has been shown (E). Values are represented as mean ± SEM of five independent 
experiments, each conducted in triplicates. 
*p < 0.05 indicates statistically significant differences compared to the untreated con-
trol cells. ble decrease in cell survival (p<0.0001) above 80 µM 
of  ALA  at  24  h  (Figure  1A  and  B).  However,  in 
MCF7  cells,  the  viability  was  found  to  significantly 
decrease at 48 h post-ALA treatment at the relatively 
lower dose of 20 μM, whereas at 72 h, the cell viability 
was similar to that observed at 24 h (Figure 1A). On 
the other hand, MDA-MB-231 cells showed a decrease 
in viability above 80 μM at 48 h that was observed at 
24 h as well. However, the percentage viability was 
reduced at 48 h compared to that at 24 h. There was no 
appreciable  difference  in  MDA-MB-231  cells  post-
ALA treatment at 72 h compared to the 24 h treatment 
period (Figure 1B). These data suggest that both breast 
cancer cell lines seem to be more sensitive to ALA 
treatment at 48h.  
In the cervical cancer cell line SiHa, ALA was 
found to decrease the viability after a 160 µM dose at 
24 h (p<0.0001). However, after incubating the cells 
with ALA for 48 h and 72 h, the viability started de-
creasing  at  20  μM  and  40  μM,  respectively  (Figure 
1C). In HeLa cells, ALA decreased the cell viability 
after 40 and 160 μM at 24 and 48h, respectively. How-
ever, at 72h, there was a significant decrease in viabil-
ity at a lower dose (20 μM) (Figure 1D).  These results 
suggest  that  cervical  cancer  cells  respond  to  ALA 
treatment  at  higher  exposure  times  (beyond  24h)  at 
lower concentrations.  Interestingly, in HEK 293 cells 
(non-cancerous),  ALA  did  not show  any  toxicity  up 
until 320 μM, implying that it was specific only for the 
cancerous cell lines (Figure 1S). 
 
ALA decreases the nitric oxide levels in breast and 
cervical cancer cell lines 
Nitric oxide plays a dual role in cancer; it can either 
promote or suppress it (Crowell et al. 2003, Lechner et 
al. 2005). To test the effect of ALA on nitric oxide 
levels,  both  the  breast and  cervical  cancer  cell  lines 
were treated with different concentrations of ALA (0-
80 μM) at different time intervals (24-72h). It was ob-
served that at 40 and 80 μM, ALA significantly re-
duced  the  levels  of  NO  by  ~3.0  and  ~2.8-fold 
(p<0.05), respectively, in MCF7 cells in 24h (Figure 
2A).  Similarly,  in  MDA-MB-231  cells,  there  was  a 
~3.4 and 3.6-fold (p<0.05) decrease in NO at 40 and 
80  μM  concentration  of  ALA,  respectively,  in  24h 
(Figure 2B). On incubating the cells until 48 and 72h, 
the trend in the decrease in NO was similar to that ob-
served at 24h, however, it was more significantly de-
creased  in  24h  of  treatment.  The  intracellular  nitric 
oxide levels were also measured using the fluorescent 
dye DAF-FM; both cell lines showed an appreciable 
decrease (Figure 2Sa). The decrease in NO was further 
confirmed by analyzing the effect of ALA on iNOS 
expression at mRNA level that showed a significant 
dose  dependent  decrease  compared  to  the  untreated 
control cells in both MCF-7 (Figure 2C) and MDA-
MB-231 (Figure 2D) cell lines. Densitometric analysis 
of  iNOS  expression  was  performed  using  the  phos-
phorimager (Figure 2E) and normalized with respect to 
β-actin as an internal control. 
In  the  SiHa  cervical  cancer  cell  line,  it  was 
observed that ALA significantly reduced the levels of 
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Figure 4. ALA increases lipid peroxidation in breast and cervical cancer cells. All the cell lines were treated for 24 h. ALA in-
duced lipid peroxidation in breast (A) and cervical cancer (B) cells, as shown by TBARs assay. The TBAR values were normal-
ized by the protein concentration of each sample estimated by the Bradford reagent. Values are represented as mean ± SEM of 
five independent experiments. *p<0.001 indicates statistically significant differences compared to the untreated control. NO by ~2.6 and 2.7-fold (p<0.0001) at 40 and 80 μM, 
respectively (Figure 3A). On the other hand, in HeLa 
cells, the NO levels were reduced by ~1.7 and 1.8-fold 
(p=0.0010)  at  40  and  80  μM,  respectively,  in  24  h 
(Figure 3B). In this case, after treating the cells with 
ALA for  48 and 72h, the trend in the decrease in NO 
was similar to that observed at 24h, however, it was 
more significantly reduced after 24h of treatment. The 
intracellular nitric oxide levels were measured by us-
ing the fluorescent dye DAF-FM; SiHa showed a sig-
nificant  decrease  in  NO  levels  compared  to  HeLa 
(Figure 2Sb). Moreover, the decrease in NO was sup-
ported by the corresponding decrease in iNOS expres-
sion at the mRNA level in a dose-dependent manner, 
compared to the untreated control cells in both HeLa 
(Figure 3D) and SiHa (Figure 3C) cells. Densitometric 
analysis of iNOS expression was performed using the 
phosphorimager (Figure 3E). 
 
ALA increases lipid peroxidation in breast and cer-
vical cancer cell lines 
Since ALA decreased the nitric oxide release in our 
study and NO is known to either inhibit or promote 
lipid  peroxidation  (Cauwels  et  al  2005,  Miles  et  al. 
1996), we analyzed the effect of ALA on lipid peroxi-
dation in both breast and cervical cancer cell lines. It 
was observed that ALA increased lipid peroxidation at 
all doses in both types of cancer cell lines; the increase 
was more significant at 40 μM. At this dose, ALA in-
creased the lipid peroxidation by ~1.6 (p=0.0038) and 
~2-fold (p=0.0002) in MCF-7 and MDA-MB-231, re-
spectively  (Figure  4A).  On  the  other  hand,  in  SiHa 
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Figure 5. ALA induces apoptosis in breast cancer cells.  Breast cancer cells, MCF-7 and MDAMB231, (1 x 10
5cells/well) were 
treated with ALA for 24 h. Decrease in mitochondrial membrane potential was analyzed by MARS data analysis software 
2.10R3 (BMG Labtech) (A). All the data are presented as means ± SEM of three independent experiments. p < 0.05 indicate 
statistically significant differences compared to the control untreated group. Caspase 3 (17/21 kDa) expression was determined 
in ALA treated MCF-7 (B) and MDAMB231 (C) cell lines. The histogram depicts densitometric analysis of western blots of 
caspase 3 (D). Values are represented as mean ± SEM of three independent experiments p<0.001 indicate statistically signifi-
cant differences compared to the untreated control cells.  cells, ALA showed a dose-dependent increase in lipid 
peroxidation (LPO) wherein at 80 μM concentration, a 
~2.6-fold increase in LPO was observed. However, in 
HeLa  cells,  there  was  a  dose-dependent  increase  in 
LPO until 40 μM ALA treatment wherein there was a 
~2.2-fold  (p=0.0017)  increase  in  lipid  peroxidation 
(Figure 4B).  
 
ALA induces apoptosis in breast and cervical can-
cer cell lines 
The loss of mitochondrial membrane potential 
is the hallmark of apoptosis (Wang et al. 2009). Since 
ALA decreased NO and increased LPO, we wanted to 
analyze whether ALA induced apoptosis in both can-
cer cell types. Thus, we evaluated the effect of ALA on 
the mitochondrial membrane potential in both breast 
and cervical cancer cells. It was observed that it sig-
nificantly reduced (p<0.0001) the mitochondrial mem-
brane potential in breast cancer cell lines (MCF-7 and 
MDA-MB-231)  in  a  dose-dependent  manner  (Figure 
5A). This was supported by a corresponding increase 
in the expression of caspase 3 (17/21 kDa) in ALA- 
treated MCF7 (Figure 5B) and MDA-MB-231 (Figure 
5C) cells compared to the untreated control cells. Den-
sitometric analysis of caspase 3 expression was per-
formed by the phosphorimager (Figure 5D) and nor-
malized with respect to tubulin as an internal control. 
On the other hand, in SiHa cells, there was a 
dose-dependent  decrease  in  the  mitochondrial  mem-
brane potential that correlated with a dose-dependent 
increase in caspase 3 expression. In  HeLa cells,  the 
decrease  in  mitochondrial  membrane  potential  was 
observed more significantly at 20 μM of ALA. How-
ever, there was a significant dose-dependent increase 
in caspase 3 expression in HeLa suggesting that ALA 
induced apoptosis in cervical cancer cells (Figure 6A). 
Densitometric  analysis  of  caspase  3  expression  was 
performed by the phosphorimager (Figure 6D).  
All these results suggested that ALA induced 
apoptosis in both breast and cervical cancer cell lines 
through activation of caspase 3 and a decrease in the 
mitochondrial membrane potential. 
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Figure 6. ALA induces apoptosis in cervical cancer cells. ALA decreases the mitochondrial potential in the cervical cancer cell 
lines SiHa and HeLa. The data was analyzed by the MARS data analysis software 2.10R3 (BMG Labtech). (A) All data are pre-
sented as means ± SEM of three independent experiments. p < 0.05 indicate statistically significant differences compared to the 
control untreated group. Caspase 3 (17/21 kDa) expression was determined in ALA-treated SiHa (B) and HeLa (C) cell lines. 
The histogram depicts densitometric analysis of western blots of caspase 3 (D). Values are represented as mean ± SEM of three 
independent experiments. p<0.001 indicate statistically significant differences compared to the untreated control cells. 
 Discussion 
 
  Omega-3 (n-3) and omega-6 (n-6) polyunsatu-
rated fatty acids (PUFAs) are the essential fatty acids 
that are important for human health. Various studies 
suggest that the dietary fatty acids play an important 
role in carcinogenesis wherein the n-3 fatty acids have 
anti-carcinogenic potential and n-6 fatty acids are pro-
cancerous (Barceló-Coblijn & Murphy 2009, Sinclair 
et  al.  2002,  Stark  et  al.  2008).  Alpha-linolenic  acid 
(C18:3n-3, ALA), the most abundant n-3 PUFA, is an 
essential fatty acid in the human diet and is present in 
green leaves, oil, seeds (flaxseed, canola, perilla) and 
nuts. It has been shown to reduce the growth of various 
cancers including breast and cervical cancer (Horia & 
Watkins 2005, Kim et al. 2009, Sagar & Das 1995). 
Even though epidemiological studies showing a direct 
correlationsip  between  ALA  intake  and  cancer  re-
sponse are limited (De Stefani et al. 1998, Franceschi 
et al. 1996), there are studies showing association be-
tween low levels of ALA in adipose tissue of patients 
with  high  risk  of  breast  cancer  (Klein  et  al.  2000). 
There are reports suggesting that high ALA diets can 
inhibit  the  growth  of  spontaneous  or  carcinogen  in-
duced mammary tumors (Fritsche et al. 1990, Hirose 
et al.1990, Kamano et al. 1989, Munoz et al. 1995). 
The  average  intake  of  ALA  in  European  countries, 
USA and Canada has been shown to range between 0.8 
and 2.2 g/d (Burdge & Calder 2005). In the UK the 
intake of ALA has risen from a mean of 1.4 g/d in 
1987–8 to 2.1 g/d according to the British Adult Diet 
Survey (Henderson et al. 2004). Since, the conversion 
of ALA into longer ω-3 PUFAs is generally considered 
low, it has been shown that a moderate consumption of 
walnuts  (4  walnuts/day  for  3  weeks)  markedly  in-
creases the blood levels of ALA and its metabolic de-
rivative, EPA. 
In the current study, we have focused on ana-
lyzing the effect of ALA on modulation of growth of 
breast and cervical cancer cells in terms of regulation 
of nitric oxide and lipid peroxidation. ALA decreased 
the nitric oxide levels in both cancer cell types. It is 
well-known  that  high  levels  of  NO  have  both 
genotoxic and angiogenic properties (Nakamura et al. 
2006).  Increased  NO  production  catalyzed  by  the 
iNOS  enzyme  in  tumor  cells  plays  a  critical  role in 
tumor angiogenesis, cancer progression and metastasis 
(Narayanan  et  al.  2003).  ALA  has  been  reported  to 
decrease  iNOS  expression  in  the  LPS-stimulated 
macrophage cell line RAW 264.7 (Ren  et al. 2007, 
Udenigwe et al. 2009). Our results showed that ALA 
not only decreased the iNOS expression at the mRNA 
level but also reduced the intracellular levels of NO in 
both the breast and cervical cancer cell lines. Thus, the 
observed decrease in NO in both cancer cell lines by 
ALA reinstates its antineoplastic potential. 
PUFAs have been shown to initiate free radical 
production and the generation of lipid peroxide prod-
ucts, selectively in tumor cells (Das 2002, Sun et al. 
2012). Several studies with ALA have shown that it 
increased  lipid  peroxidation  in  breast  cancer  cells 
(Menéndez et al. 2001, Pardini 2006). Moreover, an 
inverse  correlation  has  been  reported  between  lipid 
peroxidation and cell proliferation (Das 2002). In line 
with this, we found that ALA increased the lipid per-
oxidation with a simultaneous decrease in cell prolif-
eration  in  both  breast and  cervical cancer  cell  lines. 
Recently, it was demonstrated that peroxidized prod-
ucts of n-3 PUFAs suppress iNOS induction and NO 
production in a peroxidation-dependent manner (Araki 
et al. 2011). Thus, the observed decrease in NO in both 
types of cancer cell lines may be partly due to NO sup-
pression  by  peroxidized  products  of  ALA.  A  strong 
association  between  decreased  NO  levels  and  in-
creased lipid peroxidation has been reported in several 
papers. For example, it was found that patients suffer-
ing  from  fibromyalagia  had  higher  serum  levels  of 
TBARS  (particularly,  malondialdehyde)  and  lower 
levels  of  nitrite  compared  to  the  control  groups 
(Ozgocmen et al. 2006). Another report has shown that 
a decrease in the level of NO in rats treated with al-
loxan-induced diabetes was associated with increased 
levels of lipid peroxides (Mohan & Das, 2001). Thus, 
increase in lipid peroxides may lead to increased free-
radical generation that may inactivate NO, resulting in 
its low levels.  
Mitochondria  play  an  important  role  during 
apoptosis (Wang et al. 2009). Reactive oxygen species 
can  directly  activate  the  mitochondrial  permeability 
transition  and  result  in  loss  of  mitochondrial  mem-
brane potential (ΔΨ), which results in the release of 
cytochrome  c  (cyt  c)  and  activation  of  the  caspase 
pathway (Cao et al. 2010, Kim et al. 2005, Lee et al. 
2008, Sun et al. 2012). Our results showed that ALA 
reduced nitric oxide levels and increased lipid peroxi-
dation  in  both  breast  and  cervical  cancer  cells;  this 
may be responsible for the observed apoptosis (Figure 
7).  Conversely,  increased  nitric  oxide  has  been  re-
ported to inhibit lipid peroxidation by scavenging lipid 
peroxyl  radicals  (Hogg  &  Kalyanaraman  1999).  In-
creased NO has also been shown to prevent activation 
of  caspase  3  resulting  in  inhibition  of  apoptosis 
(Maejima et al. 2005, Mahidhara et al. 2003, Kim et al 
1997, Zhou et al. 2005). Thus, the increased LPO in 
the presence of ALA leads to a decrease in NO result-
ing  into  disruption  of  the  mitochondrial  membrane 
potential and activation of caspase 3 causing apoptosis 
(Figure 7). Taken together, our data suggest that ALA 
Journal of Molecular Biochemistry, 2013   14 regulates the growth of breast and cervical cancer cells 
through regulation of lipid peroxidation as well as ni-
tric oxide generation that may lead to apoptosis. 
 
Conclusion 
 
Omega 3 fatty acids are known to exert anticancer ef-
fects  through  various  mechanisms.  One  of  them  is 
through the generation of free radicals while another is  
through lipid peroxidation (Sun et al. 2012). Most of 
the research work to date has analysed the significance 
of  EPA  and  DHA  in  cancer  with  very  few  data  re-
ported on ALA. Our paper has tried to delineate the 
anticancer properties of ALA in terms of its potential 
to regulate lipid peroxidation as well as nitric oxide 
generation that in turn result in the control of carcino-
genesis. However, more studies are required in the fu-
ture to elucidate the role of PUFAs in governing the 
inter-relationship  between  the  nitric  oxide  and  lipid 
peroxidation status of cells for the regulation of cancer 
growth. 
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